Matrix extracellular phosphoglycoprotein (MEPE) correlates with serum phosphorus prior to and during octreotide treatment and following excisional surgery in hypophosphatemic linear sebaceous nevus syndrome.
Hoffman
William H
WH
Department of Pediatrics, Pediatric Endocrinology, Medical College of Georgia, Augusta, Georgia.
Jain
Alka
A
Chen
Harold
H
Fedarko
Neal S
NS
D000293:Adolescent; D002117:Calcitriol / Q000627:therapeutic use; D016326:Extracellular Matrix Proteins / Q000097:blood*; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D017674:Hypophosphatemia / Q000188:drug therapy*; D008297:Male; D054000:Nevus, Sebaceous of Jadassohn / Q000601:surgery*; D015282:Octreotide / Q000627:therapeutic use*; D010750:Phosphoproteins / Q000097:blood*; D010758:Phosphorus / Q000097:blood*
D016326:Extracellular Matrix Proteins; D006023:Glycoproteins; C486579:MEPE protein, human; D010750:Phosphoproteins; D010758:Phosphorus; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D002117:Calcitriol; D015282:Octreotide